Holiday Hearts: ‘Tis the Season to Give

IMG_0285

This holiday season, Alliance Life Sciences is playing Santa!

Organized through the YWCA in Buck’s County, Pennsylvania, the Holiday Hearts program is about making a small difference in the lives of children who need it most.

Alliance took the wish lists of eight underprivileged children, ages 6-11, and purchased everything each child requested — three needs and three wants. Through the program, Alliance also provided grocery gift cards to the children’s families as a way to make the season brighter.

Here’s to a new tradition that we hope will inspire others to reach out to those who could use a helping hand or some good cheer.

Happy Holidays!

The World in Your Hands: Global Pricing Data Gives Pharmcos a Much-Needed Edge

Pharma companies are under a lot of pressure these days. In the war to gain a competitive advantage, they have to be careful not to fall into price gouging, while grappling with an array of other obstacles: biosimilars, price erosion, international reference pricing and an ever-evolving marketplace.

It’s easy to feel overwhelmed by the application of international reference pricing and its influence on pricing mechanisms across the globe, especially in the wake of its adoption by countries across Europe and also Canada, Japan, South Korea, Mexico, New Zealand and other countries.

How can pharmcos actively and efficiently analyze trends, and determine how the market will react when competing products are approved or launched? Seems impossible, but the tools to do just that are within your grasp. It’s all about leveraging pricing data and using it to identify competitive threats and trends, especially for smaller companies looking for an edge over Big Pharma.

By using a high-quality, robust global pricing solution, pharmcos can optimize their pricing strategy based upon an in-depth understanding of how the global markets work, map international reference rules and define an optimal launch order when marketing a new medication. 

Smarter decision-making tools also enable pharmcos to gain better insights around treatment costs for prevalent diseases. Consider a cost-of-treatment analysis as a way to identify the most effective treatment approach for the same disease. You need the power to analyze key factors, such as unit price, age, weight, patient compliance and treatment duration.

Alliance Life Science offers a high-quality, robust global data solution:

  • Accuracy through expert review
  • Flexibility in data configurability and integration that can be customized to exact needs
  • Freshness, with updates up to five to eight weeks faster than other solution providers
  • Coverage, ranking high in country coverage when benchmarked against the competition
  • Quick and easy access to competitor drug-price information across 80+ markets

Having the most up-to-date and accurate information provides a good benchmark for companies, helping them to minimize revenue leakage, develop effective pricing strategies for new drugs, and manage ongoing pricing and reimbursement changes to maximize revenue.

Read more thought-leadership from Alliance Life Sciences on this topic:

FiercePharma: Want to win on pricing? Take a closer look at the numbers

Contract Pharma: How Pharma Manufacturers Can Gain a Competitive Edge with Advanced Pricing Data and Analytics

WTN News: Global Pricing Data and Analytics: The Defining Factor for Success 

So You Want To Be A Consultant?

As a consultant for pharmaceutical and biotechnology companies, I provide strategies on how to effectively manage revenue and improve business processes by optimizing contract strategies, minimizing revenue leakage, and constructing comprehensive reports for more accurate forecasting.

In simpler terms, I help companies streamline costs and become more competitive in an increasingly complex and demanding marketplace. While it’s not easy, it is exciting. The global pharma industry today faces unprecedented market pressures, shrinking pipelines, stiff competition and an unstable regulatory environment.

Like clutch hitters, consultants are called in to make the game-winning decisions. We help companies focus on best practices and outcomes – and develop the best possible business models. Being an effective player in this realm requires motivation, intelligence and insight, but the benefits of working at a consulting company are enormous.

Key Benefit #1: You Are Always Learning – and Teaching

Every new project brings a wealth of new experiences and learning opportunities for a consultant. Unlike the typical routine of day-to-day responsibilities that comprise most industry jobs, a consultant’s responsibilities change from moment-to-moment, guided by the company’s most urgent needs. In the process, you have an opportunity to develop new strategies, apply tried-and-true practices and share expertise. You also gain knowledge across vast areas of the industry at an accelerated pace. Throughout this process, you are constantly finding new ways to leverage your experience across multiple clients to determine the best possible fix or course of action.

Key Benefit #2: You Are the Product

Maybe the greatest part about consulting is that you are able to mold yourself into the product that your client needs the most. Often times working at a large corporation means supporting your employer in a certain field such as finance, operations, human resources, or research and development in order to assure the success of their product.  As a consultant, you are the product!  Your employer’s success depends entirely on how much your clients value you.  They turn to you for advice, and you become an essential factor in their success. It’s a great feeling!

In essence, consultants sell themselves as that invaluable missing piece that could shape a company’s next big break-through. Once they see the results of your critical input, they see you as an indispensable part of the decision-making team.

Why Do Companies Need Consultants?

The best consultants benefit their clients in many ways:

  • extension of their own team
  • go-to resource for problem-solving
  • trusted advisor
  • key strategic partner
  • add value to every initiative

The greatest consultants provide a high-level of contact, execute well, and add tremendous strategic value to projects — and to the overall business. Maybe the most important benefit that consultants can provide is peace of mind.

Alliance Life Sciences Formalizes Software Organization, Launches Separate Division

SOMERSET, N.J. / LONDON – October 27, 2014 – Alliance Life Sciences Consulting Group (ALSCG), a leading global life sciences consultancy and technology provider, announces the launch of a separate division focused on life sciences price optimization software and the appointment of Mark Costa as senior vice president of Products to lead and drive the strategic and operational direction of this new software product division.

Costa brings over 20 years of software sales and management experience primarily in life sciences to this division, created as a separate group from the Company’s service offerings in order to provide more effective product development and better alignment with market needs.

Alan Crowther, CEO, ALSCG, says, “Costa has relationships with many of the top 25 pharmaceutical companies, and comes on board at an exciting time for our organization as we experience the growth of this newly created division. We built this separate software division to support an appropriate structure for growth and to allow the right partner ecosystem to evolve around the product. Costa is absolutely the right person to accomplish these objectives, while delivering great customer satisfaction.”

Coming most recently from Revitas, a global life sciences revenue management software company, Mr. Costa is an expert in complex enterprise solution lifecycles and customer adoption of new technologies within the global revenue management segment of the life sciences industry. As founder of multiple information technology businesses, Costa has the experience to direct entrepreneurial and high performance organizations and teams, propelling them to meet and exceed goals and generate the customer satisfaction necessary to sustain high year-over-year revenue growth.

Costa says, “It is exciting, and an honor, to be part of the ALSCG organization. The new structure will help to deliver more value to our customers and partners. I’m looking forward to driving our software business, focused on our customers’ business and their success.”

 

Insight. Innovation. Impact. Integrity.

During the first quarter of 2014, Alliance began our journey to develop a new message that would embody our company as a whole.  Our clients and internal team provided feedback that shaped a new prospective leading to the launch of our re-branding.  Through all of our development activities, one theme prevailed, the importance of our customers.  The ultimate outcome being, that it’s not about what we do but who we do it for and how they benefit.

Keeping both the feedback and the end goals of our customers in mind we developed our new tagline Insight. Innovation. Impact. Integrity. Through this process, we found that it’s not our knowledge, solutions, and proprietary tools that our company thrives on. It’s the team of passionate people.

Who better to ask what the new Alliance brand means then those people themselves? Check out their responses at the link below.

https://www.youtube.com/watch?v=qvIyErRkDII&list=UUiPA3dAD-HVHSyfsVgQ5mmg

To celebrate the re-birth of our brand, we held a “brand day” party on September 26th, 2014, which luckily for us, and our executive team whom were elected to take the ALS Ice Bucket challenge, ended up being a warm Indian summer day.  Equipped with a Taco truck and various team building activities the day left our team with high moral and many laughs to take with us.

taco truck

 

Alliance’s V.P.Global Client Development Jon Kizner and Executive V.P, Global Sales and Marketing Jeff Erb order lunch!

ring toss

 

CFO Jason Watters playing Ring Toss to raise money for ALS.

ice bucket challenge

CEO Alan Crowther takes the ALS Ice Bucket Challenge.

 

Alliance Life Sciences Launches New Brand and Website Brings Focus to Customer Centric Impact

SOMERSET, N.J. / LONDON – September 29, 2014 – Alliance Life Sciences Consulting Group (ALSCG), a leading global life sciences consultancy and technology provider, announces the re-launch of its brand and website at http://www.alscg.com.

After a thorough review of its brand positioning and their client’s motivations for engagement, the company debuts it’s new positioning through the tagline: “Insight. Innovation. Impact. Integrity.”

ALSCG is a global innovator that delivers peace of mind and unlocks business value with unique solutions to complex commercial problems. The company combines proprietary technology and consulting to maximize product portfolio value through strategy, insights, technology and customer engagement.

“Our customers think of ALSCG as the definitive go-to resource, helping them to rethink contracting, sales and marketing, pricing and market access operations to meet emerging stakeholder requirements and expectations,” says Alan Crowther, CEO of ALSCG. “We are strategically aligned with our customers to unlock business value with unique solutions to these problems.”

After conducting research utilizing an agency, Alliance‘s new brand direction closely portrays a bold and innovative approach to solving challenges within life sciences, while providing messaging that align with its customer’s motivational drivers.

Through its three practice areas that focus on revenue management through a product’s lifecycle, Alliance creates meaningful and compelling value, with global projects that have included:

  • Pricing study delivered in Switzerland
  • Global pricing system delivered in Germany
  • Health economic study for a “Top 5″ pharma company in Taiwan
  • Animal health website delivered in Chile
  • Emerging market entrance pricing strategy in India
  • Revenue contract management system delivered in the USA

Alliance Reports Record Growth in 2013: Revenue Up More than 20 Percent Over 2012, 100 Percent Growth Since 2010, Continued Profitability

Alliance Life Sciences reports record revenues in 2013, and a three-year compound annual growth rate of over 20 percent that has led to revenues nearly doubling from 2010.

“Throughout 2013, we delivered a strong line-up of services and solutions which translate into over 20 percent growth for our third straight year,” says Alan Crowther, CEO, ALSCG. “Also, our addition of Jason Watters as an experienced industry chief financial officer will help lay the foundation for continued growth.”

Watters joined ALSCG after serving as chief financial officer at McKinsey’s IT Solutions division, where he oversaw part of that division’s growth from inception to almost $200 million in revenues in five years. He brings considerable experience in high-growth consulting and IT solution environments.

In addition, ALSCG had record bookings in December 2013 and January 2014, positioning the company for another record year in 2014.

Watters states, “Based on industry trends in Life Sciences, and the growing demand for our unique mix of services, we expect over 20 percent growth in 2014 and 2015. We forecast that the firm will have grown almost 200 percent since 2010 by the end of 2015.”

Not only is ALSCG growing revenues at a significant rate, but also the firm experienced a number of major successes:

  • Three of the Top 10 Pharmaceutical Companies adopted ALSCG’s PriceRight™ global pricing solutions
  • Four of the Top 10 Pharmaceutical Companies used or renewed ALSCG’s PRICENTRIC™ global pricing data services
  • Seven successful “go-lives” at clients with Revenue Contract Management suite implementations

Crowther adds, “Our tremendous success and growth in a short time reflects the strengths of our strategy, our close relationships with our customers, and the efforts of our professionals around the globe. Building upon this momentum, we will continue to offer customers the management, technology and software products they need to solve business problems, maximize revenue and achieve optimal pricing in an outcomes-based world.”

NJBIZ Ranks Alliance Life Sciences in Top 10 Among Technology Consultant Service Companies in New Jersey

Alliance Life Sciences has been ranked number eight among New Jersey’s technology consultant service companies by NJBIZ’s Annual Book of Lists 2014, an influential source of information for business-to-business professionals in New Jersey.

“This ranking reflects our continued growth, our record 2013 year, the quality of our employees and their dedicated approach to serving our customers,” says Alan Crowther, CEO, ALSCG.  “We are honored to be recognized by the highly respected and influential NJBIZ, and applaud their focus on critical business issues.”

ALSCG serves over 40 of the largest pharmaceutical and medical device companies, including 8 of the top-10 largest pharmaceutical manufacturers, enabling them to focus on continued investments in patient health and well-being by helping them receive fair value for their products with an integrated portfolio of services:

  • Management Consulting
  • Technology Integration
  • Solutions and Data Services

ALSCG has many specialized offerings with top strategic positions in the industry, and delivers these services with expertise across the following domains:

  • Global Pricing, Reimbursement and Market Access
  • Contract Strategy, Operations and Compliance
  • Commercial Operations and Analytics

Crowther adds, “ALSCG helps its customers maximize revenue and optimize pricing in an outcomes-based world. We employ hundreds of professionals around the globe who help firms obtain the best value for their critical healthcare initiatives. This distinction helps bring attention to our leading set of offerings and set the stage for our customers’, and our, continued success.”

One Week In

Welcome to our ALSCG Blog!

I am very excited to take the helm of Alliance Life Sciences and bring it together with the Adjility Health organization. It’s a privilege to serve both groups of employees, and all our customers.

Collectively, we have a lot to offer. We are solving complex problems across a lot of functions. We are doing great work in pricing, HEOR, contract management, clinical operations, and sales operations. We are introducing new algorithms to help our customers compete on analytics, we are creating some great technology and technology capabilities, and so on.

But what is most important in all of this is that we help our customers innovate in their work, and that we innovate in our own work. And by innovate, I mean real productivity gains and real shifts in ways of doing business. This is the source of real gain, this is how cash flow is freed up for the innovation that really matters: the research that brings new health therapies to market.

How do we show decision makers that a global trial can be executed for 3% – 5% less by optimizing site usage globally? How can a mobile app extend a pharmaceutical product into a service that has greater impact on patient outcomes?

We will spend time talking about how we are driving down the cost of our business and our customer’s business, helping manufacturers service patients and physicians better. Its not just solving a skill shortage or helping our clients with areas that are not core skills for them. Those things are nice – but we have to aim much higher, because the pressure to deliver on the industry has never been greater.

There are a lot of “first things” to get done, but one of the very first things we are doing is to get our leadership team up and active on all forms of social media, including our company blog. We have a very talented group with a lot of things to share.

Sharing these ideas with all of you, engaging in a dialogue with everyone more efficiently, is the first step in this process.

I look forward to what comes next!